세계의 ADME 독성 시험 시장 보고서(2025년)

ADME toxicology testing comprises a series of studies aimed at evaluating the potential toxicity of a substance or drug candidate based on its absorption, distribution, metabolism, and excretion (ADME) properties. These tests play a crucial role in drug development, ensuring the safety and well-being of individuals exposed to various substances.

The primary products associated with ADME toxicology testing include instruments, software solutions, assay systems, reagents, and other related items. Instruments are specialized devices or tools designed for specific purposes, commonly utilized in scientific, medical, or technical contexts. In the context of ADME toxicity testing, instruments are used for the measurement and analysis of readings. Various methods are employed in ADME toxicology testing, including cellular assay, biochemical assay, in silico, and ex-vivo approaches. These methods are complemented by technologies such as single-cell culture, high throughput screening, molecular imaging, omics technology, and other relevant technologies. ADME toxicology testing is applied to assess systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other factors. Industries that benefit from these tests include cosmetics and household products, pharmaceuticals, the animal industry, the food industry, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The ADME toxicology testing market research report is one of a series of new reports from The Business Research Company that provides ADME toxicology testing market statistics, including ADME toxicology testing industry global market size, regional shares, competitors with an ADME toxicology testing market share, detailed ADME toxicology testing market segments, market trends and opportunities, and any further data you may need to thrive in the ADME toxicology testing industry. This ADME toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adme toxicology testing market size has grown rapidly in recent years. It will grow from $10.4 billion in 2024 to $11.5 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to stringent regulatory requirements, rising drug development activities, growing concerns about drug safety, advancements in in vitro testing methods, increased outsourcing of toxicology studies.

The adme toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $17.98 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rapid expansion of biopharmaceuticals, growing emphasis on personalized medicine, emergence of advanced therapies, enhanced predictive toxicology models, global increase in chemical safety testing. Major trends in the forecast period include expansion of biomarker applications, integration of multi-omics data, regulatory emphasis on in vitro testing, collaborations and partnerships, continuous advancements in technology.

The forecast of 11.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. drug development by increasing costs for automated ADME screening platforms and metabolomic reagents imported from Singapore and Finland, potentially delaying preclinical trials and raising pharma R&D expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for novel drugs is anticipated to drive the growth of the ADME toxicology testing market in the coming years. Novel drugs are pharmaceutical substances that have not been previously approved or marketed for therapeutic purposes. ADME toxicity testing is a crucial phase in drug development to ensure that the novel drug is safe and does not produce harmful toxins in the body. For example, in January 2024, the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a U.S. Food and Drug Administration (FDA) branch, indicated that CDER approved 55 novel drugs in 2023, with 20 (36%) classified as first-in-class, compared to 37 novel drug approvals in 2022. Thus, the rising demand for novel drugs is fueling the growth of the ADME toxicology testing market.

The expanding pharmaceutical industry is expected to drive the growth of the ADME toxicology testing market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both government and private entities. This sector employs ADME toxicology testing to assess the absorption, distribution, metabolism, and excretion (ADME) characteristics of drug candidates and evaluate their potential toxicity. Such testing is essential for predicting a drug's behavior within the human body, including its absorption rates, distribution to target tissues, metabolism, and elimination. For instance, in September 2024, statistics from Cross River Therapy, a U.S.-based provider of ABA therapy services, indicated that the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicines in 2021. Projected spending is anticipated to rise to between $605 billion and $635 billion by 2025. Therefore, the growth of the pharmaceutical industry is driving the expansion of the ADME toxicology testing market.

Technological advancements are emerging as a pivotal trend gaining traction within the ADME toxicology testing market. Major companies within this sector are actively introducing innovative assay solutions embedded with advanced technologies, aiming to fortify their market standing. An illustrative example occurred in April 2022 when Charles River Laboratories International Inc., a US-based pharmaceutical company, partnered with Valo Health Inc., a US-based AI-health solutions provider, to unveil Logica. This cutting-edge AI-based drug development solution harnesses Valo's Opal Computational Platform, utilizing AI to offer ADME toxicology testing services and other drug delivery solutions, thereby revolutionizing drug development methodologies.

Prominent entities operating within the ADME toxicology testing market are integrating advanced technologies such as Cyprotex e-Store, fostering a seamless avenue for online ordering of ADME-Tox services. ADME-Tox services serve the purpose of reducing development costs and time, mitigating the risk of failure in later stages, and facilitating the identification of optimal candidates for clinical development. For instance, in October 2023, Evotec SE, a Germany-based biotechnology company, launched the Cyprotex e-Store, an e-commerce platform designed to provide convenient online access to the company's comprehensive range of ADME-Tox services. This platform streamlines and expedites the purchasing process, enabling registered users to assess and order Cyprotex' offerings at any time, seven days a week. The e-Store grants instant access to pricing details and comprehensive protocols online, allowing users to easily place, track, and reorder services as needed. This efficient platform significantly reduces service lead times, ensuring users receive their data promptly, thus enhancing overall efficiency in ADME-Tox testing processes.

In September 2022, BioIVT, a U.S.-based provider of drug development solutions, successfully acquired XenoTech for an undisclosed amount. This strategic acquisition marks a significant milestone for BioIVT, as it not only complements and strengthens its existing product portfolio but also facilitates the expansion of its offerings into new geographical regions and a wider customer base. XenoTech, a U.S.-based contract research organization, specializes in providing ADME-toxicology testing services. The acquisition underscores BioIVT's commitment to enhancing its capabilities and presence in the field of drug development.

Major companies operating in the ADME toxicology testing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systemes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

North America was the largest region in the ADME toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adme toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ADME toxicology testing market consists of revenues earned by entities by providing services such as drug discovery research, measuring gene expression, and preclinical efficacy testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The ADME toxicology testing market also includes sales of ADMET predictors, and UV spectrophotometers, which are used in providing ADME toxicology testing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

ADME Toxicology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adme toxicology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adme toxicology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The adme toxicology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Software Solutions; Assays Systems; Reagents; Other Products
• 2) By Method: Cellular Assay; Biochemical Assay; In Silica; Ex-Vivo
• 3) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology; Other Technologies
• 4) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications
• 5) By End-User: Cosmetics And Household Products; Pharmaceutical Industry; Animal Industry; Food Industry; Other End Users
• Subsegments:
• 1) By Instruments: High-Throughput Screening Instruments; LC-MS Or MS (Liquid Chromatography-Mass Spectrometry); HPLC (High-Performance Liquid Chromatography); Automated Workstations
• 2) By Software Solutions: Data Management Software; Simulation And Modeling Software; Risk Assessment Software
• 3) By Assay Systems: Cell-Based Assays; In Vitro Assays; Bioanalytical Assays
• 4) By Reagents: Biochemicals; Buffer Solutions; Culture Media
• 5) By Other Products: Kits And Consumables; Analytical Standards
• Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc.; Boehringer Ingelheim GmbH; Laboratory Corporation of America Holdings; Corning Incorporated; Eurofins Scientific SE; Agilent Technologies Inc.; Lonza Group AG; Dassault Systemes SE; Catalent Inc.; Charles River Laboratories International Inc.; Beckman Coulter Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Curia Global Inc; Promega Corporation; Takara Bio Inc; AB Sciex LLC; QPS Holdings LLC; Simulations Plus Inc.; Cyprotex; XenoTech LLC; BioIVT LLC; Absorption Systems; Creative Bioarray; SOLVO Biotechnology Rt.; Creative Biolabs Inc; Gentronix Limited; Admecell Inc.; Molecular Discovery Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. ADME Toxicology Testing Market Characteristics

3. ADME Toxicology Testing Market Trends And Strategies

4. ADME Toxicology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global ADME Toxicology Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global ADME Toxicology Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global ADME Toxicology Testing Market Growth Rate Analysis
• 5.4. Global ADME Toxicology Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global ADME Toxicology Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global ADME Toxicology Testing Total Addressable Market (TAM)

6. ADME Toxicology Testing Market Segmentation

• 6.1. Global ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Software Solutions
• Assays Systems
• Reagents
• Other Products
• 6.2. Global ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cellular Assay
• Biochemical Assay
• In Silica
• Ex-Vivo
• 6.3. Global ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture
• High Throughput
• Molecular Imaging
• OMICS Technology
• Other Technologies
• 6.4. Global ADME Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Other Applications
• 6.5. Global ADME Toxicology Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetics And Household Products
• Pharmaceutical Industry
• Animal Industry
• Food Industry
• Other End Users
• 6.6. Global ADME Toxicology Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Throughput Screening Instruments
• LC-MS Or MS (Liquid Chromatography-Mass Spectrometry)
• HPLC (High-Performance Liquid Chromatography)
• Automated Workstations
• 6.7. Global ADME Toxicology Testing Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Management Software
• Simulation And Modeling Software
• Risk Assessment Software
• 6.8. Global ADME Toxicology Testing Market, Sub-Segmentation Of Assay Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell-Based Assays
• In Vitro Assays
• Bioanalytical Assays
• 6.9. Global ADME Toxicology Testing Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biochemicals
• Buffer Solutions
• Culture Media
• 6.10. Global ADME Toxicology Testing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits And Consumables
• Analytical Standards

7. ADME Toxicology Testing Market Regional And Country Analysis

• 7.1. Global ADME Toxicology Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global ADME Toxicology Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific ADME Toxicology Testing Market

• 8.1. Asia-Pacific ADME Toxicology Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China ADME Toxicology Testing Market

• 9.1. China ADME Toxicology Testing Market Overview
• 9.2. China ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India ADME Toxicology Testing Market

• 10.1. India ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan ADME Toxicology Testing Market

• 11.1. Japan ADME Toxicology Testing Market Overview
• 11.2. Japan ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia ADME Toxicology Testing Market

• 12.1. Australia ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia ADME Toxicology Testing Market

• 13.1. Indonesia ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea ADME Toxicology Testing Market

• 14.1. South Korea ADME Toxicology Testing Market Overview
• 14.2. South Korea ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe ADME Toxicology Testing Market

• 15.1. Western Europe ADME Toxicology Testing Market Overview
• 15.2. Western Europe ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK ADME Toxicology Testing Market

• 16.1. UK ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany ADME Toxicology Testing Market

• 17.1. Germany ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France ADME Toxicology Testing Market

• 18.1. France ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy ADME Toxicology Testing Market

• 19.1. Italy ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain ADME Toxicology Testing Market

• 20.1. Spain ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe ADME Toxicology Testing Market

• 21.1. Eastern Europe ADME Toxicology Testing Market Overview
• 21.2. Eastern Europe ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia ADME Toxicology Testing Market

• 22.1. Russia ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America ADME Toxicology Testing Market

• 23.1. North America ADME Toxicology Testing Market Overview
• 23.2. North America ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA ADME Toxicology Testing Market

• 24.1. USA ADME Toxicology Testing Market Overview
• 24.2. USA ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada ADME Toxicology Testing Market

• 25.1. Canada ADME Toxicology Testing Market Overview
• 25.2. Canada ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America ADME Toxicology Testing Market

• 26.1. South America ADME Toxicology Testing Market Overview
• 26.2. South America ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil ADME Toxicology Testing Market

• 27.1. Brazil ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East ADME Toxicology Testing Market

• 28.1. Middle East ADME Toxicology Testing Market Overview
• 28.2. Middle East ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa ADME Toxicology Testing Market

• 29.1. Africa ADME Toxicology Testing Market Overview
• 29.2. Africa ADME Toxicology Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa ADME Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa ADME Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. ADME Toxicology Testing Market Competitive Landscape And Company Profiles

• 30.1. ADME Toxicology Testing Market Competitive Landscape
• 30.2. ADME Toxicology Testing Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. ADME Toxicology Testing Market Other Major And Innovative Companies

• 31.1. Eurofins Scientific SE
• 31.2. Agilent Technologies Inc.
• 31.3. Lonza Group AG
• 31.4. Dassault Systemes SE
• 31.5. Catalent Inc.
• 31.6. Charles River Laboratories International Inc.
• 31.7. Beckman Coulter Inc.
• 31.8. PerkinElmer Inc.
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. Curia Global Inc
• 31.11. Promega Corporation
• 31.12. Takara Bio Inc
• 31.13. AB Sciex LLC
• 31.14. QPS Holdings LLC
• 31.15. Simulations Plus Inc.

32. Global ADME Toxicology Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The ADME Toxicology Testing Market

34. Recent Developments In The ADME Toxicology Testing Market

35. ADME Toxicology Testing Market High Potential Countries, Segments and Strategies

• 35.1 ADME Toxicology Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 ADME Toxicology Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 ADME Toxicology Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer